| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/18/2007 | CN1950358A Novel gamma secretase inhibitors |
| 04/18/2007 | CN1950352A Coumarin derivative and use thereof |
| 04/18/2007 | CN1950351A 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands |
| 04/18/2007 | CN1950348A Substituted morpholine compounds for the treatment of central nervous system disorders |
| 04/18/2007 | CN1950346A N-desmethylclozapine crystalline forms |
| 04/18/2007 | CN1950342A Novel compounds as opioid receptor modulators |
| 04/18/2007 | CN1950337A (4, 5, 6, 7-tetrahydro-1-h-indol-7-yl) acetic acid derivatives for treatment of alzheimer's disease |
| 04/18/2007 | CN1950328A Phenyl indan derivatives |
| 04/18/2007 | CN1950108A Axon regeneration promoter |
| 04/18/2007 | CN1950101A Use of peptidic compounds for the prophylaxis and treatment of chronic headache |
| 04/18/2007 | CN1950099A Composition having effect of modulating autonomic nerves and method of using the same |
| 04/18/2007 | CN1950077A Use of peroxisome proliferator activated receptor delta agonists for the treatment of ms and other demyelinating diseases |
| 04/18/2007 | CN1948315A Tricycle compounds and its application in making medicine |
| 04/18/2007 | CN1948298A Dopamine D3 acceptor portion agonist and its application |
| 04/18/2007 | CN1948297A Alkylol piperazine derivative optical isomer or its salt and its application |
| 04/18/2007 | CN1948294A Amino acid diphenyl compound |
| 04/18/2007 | CN1947790A Medicine for treating paralysis and its prepn. method |
| 04/18/2007 | CN1947786A Medicine for treating and preventing neurosis and its prepn. method |
| 04/18/2007 | CN1947767A Medicine for treating and preventing infantile mental retardation, and its prepn. method |
| 04/18/2007 | CN1947766A Medicine for treating and preventing epilepsia and demented, and its prepn. method |
| 04/18/2007 | CN1947751A External application medicated bag for treating anhypnia and its prepn. method |
| 04/18/2007 | CN1947717A Method for treating neuronal and non-neuronal pain |
| 04/18/2007 | CN1947711A Application of glutamine for preparing medicine for treating and preventing cellular sugar deficiency injury |
| 04/18/2007 | CN1947704A Medicinal water-soluble compositions contg. 20(R)-ginsenoside (Rg3), and its prepn. method |
| 04/18/2007 | CN1947692A Artificial compound black mud |
| 04/18/2007 | CN1947686A Salt-solution with health-care function |
| 04/18/2007 | CN1311081C Stem cell differentiation |
| 04/18/2007 | CN1310922C Fused bicyclic pyridine derivative as tachykinin receptor antagonist |
| 04/18/2007 | CN1310921C Bicyclic oxopyridine and oxopyrimidine derivatives |
| 04/18/2007 | CN1310918C Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 04/18/2007 | CN1310916C Hetero-bicyclic compounds |
| 04/18/2007 | CN1310911C Piperazine benzothiazoles as agents for the treatment of cerebral ischemic disorders or CNS disorders |
| 04/18/2007 | CN1310909C Novel heteroaryl derivatives, their prepn. and use |
| 04/18/2007 | CN1310908C Rapamycin 29-enols |
| 04/18/2007 | CN1310906C Indole-type derivatives as inhibitors of p38 kinase |
| 04/18/2007 | CN1310890C Isoquinoline derivatives |
| 04/18/2007 | CN1310872C Mono- and disubstituted 3-propyl gamma-aminobutyric acids |
| 04/18/2007 | CN1310678C Administration of agents for the treatment of inflammation |
| 04/18/2007 | CN1310673C Composition of multiple scattered mixture contg.polypeptide and its pharm compsn. |
| 04/18/2007 | CN1310649C Application of ginsenoside Re for preparing medicine for curing dysmnesia |
| 04/18/2007 | CN1310646C Medicinal composition containing rotundine for anayesia and giving up drug-taking |
| 04/18/2007 | CN1310636C Paederia powder injection and its preparation method |
| 04/17/2007 | USRE39575 For therapy of sleep, eating and brain disorders, wakefulness promoters; Parkinson's disease, antiischemic agents, stroke, chronic fatigue syndrome; antidepressants; schizophrenia, nervous system disorders; multiple sclerosis, cognition activators |
| 04/17/2007 | US7205435 Type B botulism toxin inhibitors |
| 04/17/2007 | US7205434 Sulphonamido-substituted bridged bicycloalkyl derivatives having a substitute on the bridgehead position; nonpeptidic compounds to treat or prevent Alzheimer's Disease by modulating the processing of amyloid precursor proteins by the putative gamma-secretas to arrest the production of beta-amyloid |
| 04/17/2007 | US7205417 Spiro compounds |
| 04/17/2007 | US7205411 for treatment of neuropathic pain |
| 04/17/2007 | US7205405 Process for preparing 3-(2-(4-(6-fluorobenzo(d)isoxazol-3-yl)-piperidin-1-yl)-ethyl)-2-methyl- 6,7,8,9-tetrahydro-4h-pyrido-(1,2-a)pyrimidin-4-one |
| 04/17/2007 | US7205403 Preferential G protein coupled receptor antagonists, such as 8-(3-amino-1-methyl-1H-pyrazol-5-yl)-1,3-dipropyl-3,7-dihydro -1H-purine-2,6-dione, used for prophylaxis of asthma, autoimmune diseases or retinopathy |
| 04/17/2007 | US7205386 Truncated CD200 |
| 04/17/2007 | US7205335 Preparation of cis-fused 3,3a,8,12b-tetrahydro-2H-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivatives |
| 04/17/2007 | US7205327 Benzoimidazole or imidazole-2-carbonyl)-amino)-3-methyl butyrylamino)-5-fluoro-4-oxo- derivatives |
| 04/17/2007 | US7205319 N-[phenyl (piperidin-2-yl) methyl]benzamide derivatives, preparation thereof, and use thereof in therapy |
| 04/17/2007 | US7205317 Pain management |
| 04/17/2007 | US7205314 Compounds for the treatment of dementia related diseases |
| 04/17/2007 | US7205307 Pyrimidines as novel openers of potassium ion channels |
| 04/17/2007 | US7205306 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 04/17/2007 | US7205300 Aryl fused azapolycyclic compounds |
| 04/17/2007 | US7205297 Substituted 5-alkynyl pyrimidines having neurotrophic activity |
| 04/17/2007 | US7205294 Selected CGRP-antagonists process for preparing them and their use as pharmaceutical compositions |
| 04/17/2007 | US7205293 Benodiazepine spirohydantoin CGRP receptor antagonists |
| 04/17/2007 | US7205292 Piperidines containing a lactam ring and a quinolinone, benzimidazolone, quinazolinone or benzodiazepinone group, e.g. N-[3R,7R)-1-(Cyclopropylmethyl)-2-oxo-7-phenylazepan-3-yl]-4-(2-oxo-1,4-dihydroquinazolin-3 (2H-yl)piperidine-1-carboxamide; treating headaches, migraine headaches and cluster headaches |
| 04/17/2007 | US7205286 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses |
| 04/17/2007 | US7205280 Methods of suppressing microglial activation |
| 04/17/2007 | US7205151 Antiinflammatory agents; skin disorders |
| 04/17/2007 | US7205139 Expression vector comprising nucleotide sequences coding serine protease for use in diagnosis and treatment of thrombotic disorders |
| 04/17/2007 | US7205120 Detection Alzheimer's disease |
| 04/17/2007 | US7205004 Using plant extracts for central nervous system disorders |
| 04/17/2007 | CA2374635C Sulfuric acid mono-[3-({1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl}-hydroxy-methyl)-2-methoxy-phenyl]ester |
| 04/17/2007 | CA2371645C Naphtalene or heterocyclically substituted benzimidazoles as parp inhibitors |
| 04/17/2007 | CA2358885C Pyrazolecarboxylic acid derivatives, their preparation, pharmaceutical compositions containing them |
| 04/17/2007 | CA2318381C Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same |
| 04/17/2007 | CA2295792C A crystalline dibenzothiazepine derivative and its use as an antipsychotic agent |
| 04/17/2007 | CA2202775C Method for treating anxiety |
| 04/14/2007 | CA2564064A1 Genetic variations associated with psychiatric disorders |
| 04/14/2007 | CA2524551A1 Use of selenium yeasts in the treatment of alzheimer's disease |
| 04/12/2007 | WO2007041712A1 Pyrazolopyrimidines as protein kinase inhibitors |
| 04/12/2007 | WO2007041506A1 Purine formulations and methods for managing disorders |
| 04/12/2007 | WO2007041435A1 Methods for treating pain and hyperhidrosis |
| 04/12/2007 | WO2007041035A2 Oral composition and method for stress reduction associated with smoking cessation |
| 04/12/2007 | WO2007041023A1 1- (1h- indol- 1-yl) -3- (methylamino) -1- phenylpropan-2-ol derivatives and related compounds as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms) |
| 04/12/2007 | WO2007040982A1 5- (phenylisoxazolylethoxy) -triazol- 3 -yl substituted pyridine compounds for the treatment of neurological, psychiatric or pain disorders |
| 04/12/2007 | WO2007040440A1 New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer’s disease |
| 04/12/2007 | WO2007040439A1 New compounds ii |
| 04/12/2007 | WO2007040438A2 Novel imidazo [4,5 -b] pyridine derivatives as inhibitors of glycogen synthase kinase 3 for use in the treatment of dementia and neurodegenerative disorders |
| 04/12/2007 | WO2007040436A1 Use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer’s disease |
| 04/12/2007 | WO2007040244A1 Composition for relieving subjective symptoms of fatigue |
| 04/12/2007 | WO2007040231A1 Quinazoline derivative and pharmaceutical |
| 04/12/2007 | WO2007040212A1 Neuronal differentiation inhibitor peptide and use thereof |
| 04/12/2007 | WO2007039869A2 Use of neboglamine in the treatment of toxicodependency |
| 04/12/2007 | WO2007039782A1 Tetrazole derivatives as modulators of metabotropic glutamate receptors |
| 04/12/2007 | WO2007039781A2 1,2,4-oxadioi.e derivatives with activity at the metabotropic clutamate receptors |
| 04/12/2007 | WO2007039773A1 Use of fused pyrrole carboxylic acids for the treatment of neurodegenerative and psychiatric diseases as d-amino acid oxidase inhibitors |
| 04/12/2007 | WO2007039761A2 Crystal structure of cd44 and its use |
| 04/12/2007 | WO2007039740A2 Preparation and use of tetrahydropyrrolo [3, 2-c] pyridin-4-one derivatives for treatment of obesity, psychiatric and neurological disorders |
| 04/12/2007 | WO2007039592A1 Polyunsaturated fatty acids as bace inhibitors |
| 04/12/2007 | WO2007039563A1 9-azabicyclo [3 . 3 . 1] nonane derivatives as monoamine reuptake inhibitors |
| 04/12/2007 | WO2007039512A1 Naphthyridin derivatives |
| 04/12/2007 | WO2007039439A1 Oxadiazolyl pyrazolo-pyrimidines as mglur2 antagonists |
| 04/12/2007 | WO2007039438A1 Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists |